Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001373451-09-000004
Filing Date
2009-10-15
Accepted
2009-10-15 19:36:53
Documents
1
Period of Report
2009-10-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3887
  Complete submission text file 0001373451-09-000004.txt   5776
Mailing Address 4225 EXECUTIVE SQUARE SUITE 460 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 460 LA JOLLA CA 92037 (858) 457-5300
TRANSDEL PHARMACEUTICALS INC (Issuer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4225 EXECUTIVE SQUARE SUITE 485 LA JOLLA CA 92037
Business Address
Schupp Joachim PH (Reporting) CIK: 0001373451 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52998 | Film No.: 091122247